Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Amgen to Acquire Privately Held Teneobio for $900 Million in Cash With Future Contingent Milestone Payments
Amgen (NASDAQ: AMGN) and Teneobio today announced an agreement under which Amgen will acquire Teneobio, a […]
Inceptor Bio Announces the Appointment of Dr. Mark J. Gilbert as Chair of its Scientific Advisory Board
Inceptor Bio, a Research Triangle Park, North Carolina-based cell and gene therapy biotechnology company, announced today […]
Aristea Completes $63 Million Series B Financing to Accelerate Clinical Development of Novel Immunotherapy Drugs for the Treatment of Orphan Diseases
Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat […]
AI Tool Promises a Breakthrough in Medical Science
A group of British AI researchers have used a computer programme named Alphafold to predict […]
AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases
AbbVie (NYSE: ABBV) and Calico Life Sciences today announced an extension of their leading-edge collaboration […]
NHS Digital Launches Data Uses Register to Improve Transparency
NHS Digital is improving transparency about how patient data is accessed by launching its new […]
Meet Peppy: London-based Women’s Health App Raises £6.6M to Directly Link Females with Specialists
Peppy, a B2B digital health platform, has announced a £6.6M Series A funding round led […]
Medtronic TYRX ™ Absorbable Antibacterial Envelope Is Effective at Reducing Infections in Cardiac Device Patients with Hematomas
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced new data from […]
Avatar-led Programme for Kidney Disease Patients Expands After Successful Pilot
An avatar-led, interactive, information programme for people with Chronic Kidney Disease (CKD) has been so […]
Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the launch of the Prevail™ […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more